SmartZyme is a medical technology company enabling a seamless leap to better performing glucose monitoring for people with diabetes. Founded by David Baram and Shilo Ben Zeev in 2013, SmartZyme BioPharma, Ltd. is backed by investors that include OrbiMed and Virtus Inspire Ventures and is headquartered in New York.